Divyadrishti Imaging Laboratory, Department of Physics, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand-247667, India.
Nanobiotechnology Laboratory, Department of Biotechnology, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand-247667, India.
Nanotheranostics. 2021 Jan 15;5(2):166-181. doi: 10.7150/ntno.56015. eCollection 2021.
Diabetes Retinopathy (DR) is one of the most prominent microvascular complications of diabetes. It is one of the pre-eminent causes for vision impairment followed by blindness among the working-age population worldwide. The de facto cause for DR remains challenging, despite several efforts made to unveil the mechanism underlying the pathology of DR. There is quite less availability of the low cost pre-emptive theranostic imaging tools in terms of in-depth resolution, due to the multiple factors involved in the etiology of DR. This review work comprehensively explores the various reports and research works on all perspectives of diabetic retinopathy (DR), and its mechanism. It also discusses various advanced non-destructive imaging modalities, current, and future treatment approaches. Further, the application of various nanoparticle-based drug delivery strategies used for the treatment of DR are also discussed. In a nutshell, the present review work bolsters the pursuit of the development of an advanced non-invasive optical imaging modal with a nano-theranostic approach for the future diagnosis and treatment of DR and its associated ocular complications.
糖尿病视网膜病变(DR)是糖尿病最显著的微血管并发症之一。它是全球工作年龄人群视力损害和失明的首要原因之一。尽管已经做出了许多努力来揭示 DR 病理学的机制,但 DR 的实际病因仍然具有挑战性。由于 DR 的病因涉及多个因素,因此在深入分辨率方面,低成本的预防性治疗诊断成像工具的可用性相当有限。 这项综述工作全面探讨了关于糖尿病视网膜病变(DR)及其机制的各个方面的各种报告和研究工作。它还讨论了各种现有的和未来的治疗方法。此外,还讨论了用于治疗 DR 的各种基于纳米颗粒的药物输送策略的应用。简而言之,本综述工作支持了对先进的非侵入性光学成像模式与纳米治疗相结合的方法的开发,以用于未来 DR 及其相关眼部并发症的诊断和治疗。